Literature DB >> 413437

Ocular findings in triploidy.

A B Fulton, R O Howard, D M Albert, Y E Hsia, S Packman.   

Abstract

We studied the abnormal ocular and systemic findings in one case of true triploidy and two cases of triploid mosaicism. A liveborn triploid child 69,XXY, had abnormalities including cebocephaly, a single midline nostril, incomplete cleft palate, transverse palmar creases, partial syndactyly, and ambiguous genitalia. Ocular abnormalities included hypotelorism, blepharophimosis, microcornia, iris coloboma, cataract, persistent hyaloid vasculature, retinal dysplasia, and optic atrophy. A 16-year-old girl with triploid mosaicism had congenital left facial and body hemiatrophy, both growth and mental retardation, left-sided grand mal seizures, incontinentia pigmenti of both legs, partial syndactyly, and generalized weakness. Results of her ocular examination were within normal limits. A 13-year-old boy with triploid mosaicism exhibited both growth and mental retardation, truncal obesity, and required a brace to support his back. Ocular findings included synophrys, bilateral blepharoptosis, and abnormal results of Schirmer tear test. Studies indicate a wide spectrum of ocular and systemic abnormalities occur that are presumably associated with the chromosome error.

Entities:  

Mesh:

Year:  1977        PMID: 413437     DOI: 10.1016/0002-9394(77)90510-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

Review 1.  Association of pigmentary anomalies with chromosomal and genetic mosaicism and chimerism.

Authors:  I T Thomas; J L Frias; E S Cantu; C Z Lafer; D B Flannery; J G Graham
Journal:  Am J Hum Genet       Date:  1989-08       Impact factor: 11.025

2.  Hypomelanosis of Ito: a manifestation of mosaicism or chimerism.

Authors:  D Donnai; A P Read; C McKeown; T Andrews
Journal:  J Med Genet       Date:  1988-12       Impact factor: 6.318

3.  Classification of chromosomal eye syndromes.

Authors:  R O Howard
Journal:  Int Ophthalmol       Date:  1981-08       Impact factor: 2.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.